ArticleVisceral medicine2026
"Islet-on-a-Chip": A Microfluidic System Design for Preservation of Viability and Function of Human Islets of Langerhans - A Systematic Review.
Article in Visceral medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There are multiple designs of microfluidic devices to study islets of Langerhans in vitro. There is an ongoing debate which design of microfluidic device is optimal in maintaining highest viability and function of the islets in vitro. Methods: A systematic literature review was conducted to evaluate the most common designs used of microfluidic devices to culture human pancreatic islets in vitro. The review included the following microfluidic designs: microwell, hanging drop, hydrodynamic trap, encapsulation, and hydrogel scaffolds. PubMed and Google Scholar databases were searched for all relevant studies (articles in English; case studies were excluded, reference period January 2013 to June 2023). Data on islet function (insulin stimulation index [ISI]) and viability, duration of experiment, design of microfluidic device, and type of cells in the experiment were collected. ANOVA was utilized for statistical analysis. Results: A total of 1,646 studies were identified in the electronic database search. There were 310 duplications, 1,152 studies were excluded after the initial screening, additionally 143 studies were excluded after reading a full-text article. Forty-one studies were included in the final analysis. The highest viability was reported in hydrogel scaffold group 97% (one study), followed by hydrodynamic trap 93.0% (±4.2), microwell 89.2% (±10.1), encapsulation 88.7% (±6.3) accordingly. ANOVA showed no difference among the designs ( Conclusion: Hydrogel scaffold design of microfluidic devices might be associated with the highest viability of islets, and islet function is best preserved by hanging drop systems. More research is needed to further investigate the optimal design for further islet viability and function in vitro.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.